The largest database of trusted experimental protocols

2 protocols using e cadherin and n cadherin antibodies

1

Analysis of CDCP1 Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
SuperScript™III, RPMI 1640 medium and Opti-MEM medium were obtained from Invitrogen (Carlsbad, CA). TriSolution Plus Reagent was from GeneMark (Atlanta, Georgia). RNAzol® RT RNA isolation reagent was purchased from Molecular Research Center, INC (Cincinnati, OH). GoScriptTM Reverse Transcriptase, Go Taq® Green Master Mix (2X), and luciferase assay system were from Promaga (Madison, WI). G418 disulfate salt was from Sigma-Aldrich (St. Louis, MO). Src inhibitor PP1 was from Calbiochem (Merck Millipore, Darmstadt, Germany). Src inhibitor-1 was from Merck Millipore (Burlington, MA, USA). HyFectTM DNA transfection reagent was from Leadgene Biomedical (Tainan, Taiwan). Antibodies against β-actin and Flag were obtained from Sigma-Aldrich (St. Louis, MO). E-cadherin and N-cadherin antibodies were obtained from BD Bioscience (Bedford, MA). MMP-2 antibody was purchased from Millipore (Billerica, MA). Antibodies against CDCP1, c-Src, pSrcTyr416, and pPKCδTyr314 were purchased from Cell Signaling Technology (Danvers, MA).
+ Open protocol
+ Expand
2

VEGF Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human VEGFA (R&D, Cat. no. 293-VE) was used for western blotting and live cell imaging experiments to stimulate VEGF signalling. Fibronectin antibody was used for western blotting (1:2,000) and immunofluorescence imaging (1:1,000) (Abcam, Cat. no. ab2413). Notch1 antibody (1:1,000) and VEGF-neutralizing antibody (1:1,000) were obtained from R&D Systems (Cat. nos. AF3647 and MAB293). Primary antibodies against Dll4 (1:500) and VEGFA (1:500) were obtained from Santa Cruz (Cat. nos. sc-365429 and sc-152). VE-cadherin (1:500), GAPDH (1:20,000) and phospho-FAKY397 (1:500) primary antibodies were obtained from Cell Signaling (Cat. nos. 2158, 2118 and 8556). Vimentin antibody was from Sigma (V6630, 1:1,000). E-cadherin and N-cadherin antibodies (1:1,000) were obtained from BD Biosciences (Cat. nos. 610181 and 610920). Alexa Fluor 555 and 647 secondary antibodies (Invitrogen) and DAPI (4′,6-diamidino-2-phenylindole; Invitrogen) were used for 3D immunofluorescence. Horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch) were used for western blotting.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!